FINWIRES · TerminalLIVE
FINWIRES

$STOK

1 story mentioning STOKUpdated 35m ago

Every FINWIRES story that references STOK, newest first.

Research

Goldman Sachs Initiates Coverage on Stoke Therapeutics With Buy Rating, $44 Price Target

$STOK

Track with the FINWIRES app suite

FolioX
FolioX
Track STOK in your portfolio
WheelAI
WheelAI
Analyze STOK options with the wheel strategy
StockInsider
StockInsider
See market sentiment on STOK